Results 61 to 70 of about 1,626,624 (288)

Glucocorticoid exposure and initiation of SSRIs among patients with rheumatoid arthritis: A nested case–control study in UK primary care

British Journal of Clinical Pharmacology, EarlyView.
Aim The immune system might affect the development of anxiety disorders, though mechanisms remain unclear. This nested case–control study investigates whether use of glucocorticoids, potent immunosuppressants, is associated with SSRI initiation (a proxy for pharmacologically treated mental disorders, predominantly depression and/or anxiety).
Elise J. Heesbeen, Patrick C. Souverein, Eibert R. Heerdink, Elisabeth Y. Bijlsma, Lucianne Groenink   +4 more
wiley   +1 more source

Drug interactions and possible serotonin syndrome in a patient with fibromyalgia

Vitae, 2014
Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran).
Patricia de Carvalho MASTROIANNI, Fabiana Rossi VARALLO, Manuel MACHUCA   +2 more
doaj  

Selective serotonin reuptake inhibitors for fibromyalgia syndrome

São Paulo Medical Journal
BACKGROUND: Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology. Fibromyalgia is characterized by chronic widespread musculoskeletal pain, sleep problems, cognitive dysfunction, and fatigue. Patients often report
Brian Walitt, Gerard Urrútia, María Betina Nishishinya, Sarah E. Cantrell, Winfried Häuser   +4 more
doaj   +1 more source

Incident low‐dose quetiapine use in adults newly diagnosed with depression in primary care: A nationwide register‐based study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to investigate the incidence of low‐dose quetiapine initiation and associated factors in adults newly diagnosed with depression in primary care. Methods We obtained medication dispensing records, primary and secondary care diagnoses and employment status for antipsychotic‐naïve individuals aged 16–65 newly diagnosed with ...
Laura Purra, Heidi Taipale, Miia Tiihonen, Markku Lähteenvuo, Jari Tiihonen, Aleksi Hamina   +5 more
wiley   +1 more source

Comparing Attention Bias Modification With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder

Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2019
Background and Aim Obsessive-Compulsive Disorder (OCD) is the fourth most common psychiatric disorder. It consists of symptoms, including intrusive thoughts, rituals, behaviors, preoccupations, and compulsions.
Khadijeh Mohsenpourian, Mostafa Nokani, Hamidreza Jamilian, Mohsen Ghasemi   +3 more
doaj  

Skin eruptions related with selective serotonin reuptake inhibitors

Psychiatry and Clinical Psychopharmacology, 2021
Objective: The aim of the present study was to provide clinical data regarding clinical and sociodemographic features of individuals who were admitted to our clinic for skin rash during treatment with selective serotonin reuptake inhibitors (SSRI ...
Ayse Suleyman, Funda Suleyman, Ilyas Kaya, Behiye Alyanak   +3 more
doaj  

Selective serotonin reuptake inhibitors’ passage into human milk of lactating women

, 2019
Objective: Selective serotonin reuptake inhibitors are commonly used for the treatment of pregnancy-related and postnatal depression. However, only a few studies have evaluated the passage of these drugs into human milk, often with conflicting results ...
Clementi Emilio, Zuccotti Gian vincenzo, Baldelli Sara, Pileri Paola, Pogliani Laura, Cattaneo Dario, Cetin Irene   +6 more
core   +1 more source

Are Selective Serotonin Reuptake Inhibitors Associated With Hepatocellular Carcinoma in Patients With Hepatitis C? [PDF]

, 2014
BACKGROUND AND AIMS: Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for patients with chronic hepatitis C virus (HCV) infection. Research suggests that serotonin promotes the development and growth of hepatocellular carcinoma
Pocha, Christine, Knott, Astrid, Rector, Thomas S., Dieperink, Eric   +3 more
core   +1 more source

Gabapentin as an add‐on analgesic to morphine in paediatric patients with chronic pain

British Journal of Clinical Pharmacology, EarlyView.
Aims Off‐label use of gabapentin for the treatment of chronic pain in children has increased over the last decade, with multiple clinical trials evaluating its role pain management and potential opioid‐sparing effects. To date, however, these studies appear to rely on empirical evidence without further consideration of pharmacokinetic‐pharmacodynamic ...
Paul Healy, Mariagrazia Felisi, Adriana Ceci, Oscar Della Pasqua, on Behalf of the GAPP Consortium, Corinne Alberti, Donato Bonifazi, Adriana Ceci, Thomas G. de Leeuw, Saskia N. de Wildt, Mariagrazia Felisi, Florentia Kaguelidou, Enora Le Roux, Rebecca Lundin, Laura Mangiarini, Dick Tibboel   +15 more
wiley   +1 more source

Effects of milnacipran on binge eating – a pilot study

Neuropsychiatric Disease and Treatment, 2008
Shun’ichi Noma1, Teruhisa Uwatoko1, Haruka Yamamoto2, Takuji Hayashi11Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 2Department of Psychiatry, Toyooka Hospital, Hyogo, JapanAbstract: Selective serotonin ...
Shun’ichi Noma, Teruhisa Uwatoko, Haruka Yamamoto, Takuji Hayashi   +3 more
doaj